Cell Source, Inc. Contracts & Agreements

77 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
AMENDMENT NO. 1 TO VETO CELL PRODUCTION AND CLINICAL TRIAL PROGRAM AGREEMENT
Cell Source, Inc.
Biotechnology
2019
Amendment No. 3 to Veto Cell Production and Clinical Trial Program Agreement, dated as of May 1, 2023, between Cell Source Limited and the University of Texas M.D. Cancer Center
Cell Source, Inc.
2024
Amendment No. 2 to Veto Cell Production and Clinical Trial Program Agreement, dated as of August 7, 2019, between Cell Source Limited and the University of Texas M.D. Cancer Center
Cell Source, Inc.
2024
Original Issue Discount Note issued to Darlene Soave Revocable Trust
Note Agreements
Cell Source, Inc.
2024
Original Issue Discount Note issued to David Zolty Investment ULC
Note Agreements
Cell Source, Inc.
2024
Original Issue Discount Note issued to Solomon Zolty Investment ULC
Note Agreements
Cell Source, Inc.
2024
Original Issue Discount Note issued to Phyllis Friedman Investment ULC
Note Agreements
Cell Source, Inc.
2024
Original Issue Discount Note issued to Honey Kamenetsky Investment ULC
Note Agreements
Cell Source, Inc.
2024
Original Issue Discount Note issued to Helen Samuels Investment ULC
Note Agreements
Cell Source, Inc.
2024
Amendment No. 3 to Sponsored Research Agreement dated November 15, 2022 between the University of Texas MD Anderson Cancer Center and Cell Source Ltd
Cell Source, Inc.
2023
Amendment No. 4 to Sponsored Research Agreement dated November 6, 2023 between the University of Texas MD Anderson Cancer Center and Cell Source Ltd
Cell Source, Inc.
2023
Amendment No. 4 to Third Amended and Restated Note
Note Agreements
Cell Source, Inc.
2023
Amendment No. 2 to 10% Convertible Note
Note Agreements
Cell Source, Inc.
2023
Amendment No. 1 to Third Amended and Restated Note
Note Agreements
Cell Source, Inc.
2023
Amendment No. 2 to Third Amended and Restated Note
Note Agreements
Cell Source, Inc.
2023
Amendment No. 3 to Third Amended and Restated Note
Note Agreements
Cell Source, Inc.
2023
Amendment No. 1 to10% Convertible Note
Note Agreements
Cell Source, Inc.
2023
Description of Common Stock
Stock Agreements
Cell Source, Inc.
Biotechnology
2022
Fifth Amendment to Research and License Agreement dated as of June 30, 2019 between the Company and Yeda Research and Development Company Limited
License Agreements
Cell Source, Inc.
2022
Amendment No. 2 to Sponsored Research Agreement dated October 18, 2021 between the University of Texas MD Anderson Cancer Center and Cell Source Ltd
Cell Source, Inc.
2022
Eighth Amendment to Research and License Agreement dated as of December 2, 2021 between the Company and Yeda Research and Development Company Limited
License Agreements
Cell Source, Inc.
Biotechnology
2022
10% Convertible Note issued to George Verstraete
Note Agreements
Cell Source, Inc.
2022
Amendment No. 2 to Sponsored Research Agreement dated October 18, 2021 between The University of Texas M.D. Anderson Cancer Center and Cell Source Limited
Cell Source, Inc.
2021
Third Amended and Restated 10.0% Convertible Note
Note Agreements
Cell Source, Inc.
Biotechnology
NJ
2021
Form of Note Exchange Agreement between Cell Source, Inc. and holder of 10% OID Convertible Promissory Note
Exchange Agreements
Cell Source, Inc.
Biotechnology
NV
2021
Second Amended and Restated 10.0% Convertible Note
Note Agreements
Cell Source, Inc.
Biotechnology
NJ
2021
Form of warrant issued to holder of Second Amended and Restated 10.0% Convertible Note
Warrant Agreements
Cell Source, Inc.
2021
Seventh Amendment to Research and License Agreement dated November 15, 2020 between Yeda Research and Development Company Limited and Cell Source Limited
License Agreements
Cell Source, Inc.
2021
Form of 8% Convertible Promissory Note
Note Agreements
Cell Source, Inc.
Biotechnology
NJ
2020
Form of Warrant issued to Members of Scientific Advisory Board
Warrant Agreements
Cell Source, Inc.
Biotechnology
NY
2020
Form of Warrant issued to Service Providers
Warrant Agreements
Cell Source, Inc.
2020
Form of Director Stock Option Agreement
Stock Agreements
Cell Source, Inc.
2020
Form of Warrant issued to Purchasers of 8% Convertible Promissory Note
Warrant Agreements
Cell Source, Inc.
Biotechnology
NY
2020
Form of Consultant Stock Option Agreement
Stock Agreements
Cell Source, Inc.
2020
Form of Warrant issued to purchaser of 10% OID Convertible Promissory Note
Warrant Agreements
Cell Source, Inc.
2020
Form of 10% OID Convertible Promissory Note
Note Agreements
Cell Source, Inc.
Biotechnology
NJ
2020
Form of Securities Purchase Agreement between Cell Source, Inc. and the purchaser of 10% OID Convertible Promissory Note
Note Agreements
Cell Source, Inc.
Biotechnology
NJ
2020
Form of Placement Agent Warrant dated February 13, 2020
Warrant Agreements
Cell Source, Inc.
Biotechnology
NY
2020
Convertible Promissory Note dated January 10, 2020
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2020
Sixth Amendment to Research and License Agreement effective December 31, 2019 between Yeda Research and Development Company Limited and Cell Source Limited
License Agreements
Cell Source, Inc.
2020
Convertible Note effective October 28, 2019
Note Agreements
Cell Source, Inc.
2020
CELL SOURCE, INC. 2019 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT
Bonus & Incentive Agreements
Cell Source, Inc.
2019
CELL SOURCE, INC. 2019 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT
Bonus & Incentive Agreements
Cell Source, Inc.
Biotechnology
NV
2019
CELL SOURCE, INC. 2019 EQUITY INCENTIVE PLAN
Bonus & Incentive Agreements
Cell Source, Inc.
Biotechnology
NV
2019
SPONSORED RESEARCH AGREEMENT
Cell Source, Inc.
Biotechnology
TX
2019
ยง 1 Subject matter
Cell Source, Inc.
2019
FOURTH AMENDMENT TO RESEARCH AND LICENCE AGREEMENT (this Amendment) Effective Date: March 30, 2018 By and between YEDA RESEARCH AND DEVELOPMENT COMPANY LIMITED a company duly...
Development Agreements
Cell Source, Inc.
2018
THIRD AMENDMENT TO RESEARCH AND LICENCE AGREEMENT Made and entered in to this 29th day of March, 2018 By and between YEDA RESEARCH AND DEVELOPMENT COMPANY LIMITED a company duly...
Development Agreements
Cell Source, Inc.
Biotechnology
2018
SECOND AMENDMENT TO RESEARCH AND LICENCE AGREEMENT (this Amendment) Effective Date: November 28, 2016 By and between YEDA RESEARCH AND DEVELOPMENT COMPANY LIMITED a company duly...
Development Agreements
Cell Source, Inc.
Biotechnology
2018
WARRANT
Warrant Agreements
Cell Source, Inc.
2018
PROMISSORY NOTE
Note Agreements
Cell Source, Inc.
2016
Original Issue Date: January 27, 2015$250,000.00 CONVERTIBLE NOTE DUE JULY 27, 2016
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2016
SUBSCRIPTION AGREEMENT
Subscription Agreements
Cell Source, Inc.
Biotechnology
NY
2016
CONVERTIBLE NOTE DUE [*], 20[*]
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2016
PROMISSORY NOTE OF CELL SOURCE, INC.
Note Agreements
Cell Source, Inc.
2016
WARRANT
Warrant Agreements
Cell Source, Inc.
Biotechnology
NY
2016
By:Name:Title:Cell Source, Inc.
Cell Source, Inc.
Biotechnology
2015
CONVERTIBLE PROMISSORY NOTE OF CELL SOURCE, INC.
Note Agreements
Cell Source, Inc.
2015
PROMISSORY NOTE OF CELL SOURCE, INC.
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2015
WARRANT
Warrant Agreements
Cell Source, Inc.
2015
WARRANT
Warrant Agreements
Cell Source, Inc.
Biotechnology
NY
2015
CONSULTING/ADVISORY AGREEMENT
Cell Source, Inc.
2015
WARRANT TO PURCHASE COMMON STOCK VOID AFTER 5:30 P.M., EASTERN TIME, ON THE EXPIRATION DATE
Warrant Agreements
Cell Source, Inc.
2015
PROMISSORY NOTE OF CELL SOURCE, INC.
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2015
CELL SOURCE, INC. 65 Yigal Alon Street Tel Aviv, Israel 67433
Cell Source, Inc.
2015
WARRANT TO PURCHASE COMMON STOCK VOID AFTER 5:30 P.M., EASTERN TIME, ON THE EXPIRATION DATE
Warrant Agreements
Cell Source, Inc.
Biotechnology
NY
2015
PROMISSORY NOTE OF CELL SOURCE, INC.
Note Agreements
Cell Source, Inc.
2015
PROMISSORY NOTE
Note Agreements
Cell Source, Inc.
2014
BRIDGEFUNDING AGREEMENT Made and signed as of the 23rd day of October,2013
Cell Source, Inc.
2014
THIRD AMENDMENT TO EVALUATION AND EXCLUSIVEOPTION AGREEMENT Made and entered in to this 15th day ofAugust, 2014 By and between YEDA RESEARCH AND DEVELOPMENT COMPANYLIMITED a...
Development Agreements
Cell Source, Inc.
2014
AMENDMENT NO.1 TO REGISTRATION RIGHTSAGREEMENT
Cell Source, Inc.
2014
CELL SOURCE, LTD. WARRANT TO PURCHASE ORDINARY SHARES
Warrant Agreements
Cell Source, Inc.
Biotechnology
NY
2014
SHARE EXCHANGE AGREEMENT
Exchange Agreements
Cell Source, Inc.
2014
SUBSCRIPTION AGREEMENT
Subscription Agreements
Cell Source, Inc.
2014
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
Cell Source, Inc.
2014
Cell Source, Inc. . Warrant to Purchase Common Stock
Warrant Agreements
Cell Source, Inc.
Biotechnology
2014
WARRANT TO PURCHASE COMMON STOCK VOID AFTER 5:30 P.M., EASTERN TIME, ON THE EXPIRATION DATE
Warrant Agreements
Cell Source, Inc.
Biotechnology
NY
2014